• LAST PRICE
    11.2000
  • TODAY'S CHANGE (%)
    Trending Down-0.8000 (-6.6667%)
  • Bid / Lots
    8.4000/ 1
  • Ask / Lots
    12.6400/ 1
  • Open / Previous Close
    11.6300 / 12.0000
  • Day Range
    Low 11.2000
    High 11.9000
  • 52 Week Range
    Low 0.8000
    High 14.2600
  • Volume
    4,385
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Oct 21, 2024

      Show headlines and story abstract
    • 7:30AM ET on Monday Oct 21, 2024 by Dow Jones
      Companies Mentioned: FNCH

      Finch Announces Delisting from Nasdaq and SEC Deregistration

      BOSTON, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (Nasdaq: FNCH) ("Finch" or the "Company"), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today announced that it has provided notification to The Nasdaq Stock Market, LLC ("Nasdaq") of its intent to delist the Company's common stock, par value $0.001 per share (the "Common Stock"), from the Nasdaq Global Select Market. Finch expects to file a Form 25 (Notification of Removal from Listing) with the Securities and Exchange Commission (the "SEC") and Nasdaq relating to the delisting of its Common Stock on or about October 31, 2024. The removal of the Common Stock from Nasdaq will be effective 10 days after the filing of the Form 25.

Peers Headlines